SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Cryogenic Solutions Inc. (CYGS)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: celeryroot.com who wrote (3211)8/19/1998 4:35:00 PM
From: Graham Marshman  Read Replies (1) of 4028
 
Well this is the Barr definition from the reference I gave you:

"The first phase -- preclinical research -- involves laboratory and animal testing of the compound which is primarily aimed at establishing safety and efficacy. If successful, the innovator can then file an Investigational New Drug Application (IND) with the FDA, seeking approval to move the compound into a three phase process of human testing."

What's your view of succesful completion of preclin.?

Re CYGS - depends how you split it up - on a product by product basis, not company. My view of the total delivery vector is they're in preclinical. If you looked at specific delivery vector to HeLa cells, that could be considered to have completed preclin.

So if not preclinical, where did they say they were?

Graham
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News